Payment overview · 2025
General Payments
$365.98
15 reported records · 7 companies
Healthcare provider profile · identity verified
Adel Boutros, MD
Allopathic & Osteopathic Physicians|Family Medicine · LAKE FOREST, CA · NPI 1700952827
Verified facts
What the public records show
CMS Open Payments records show Adel Boutros, MD received $365.98 in general payments during 2025 across 15 reported records.
Vanda Pharmaceuticals Inc. accounted for 37.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 11 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Austedo Xr, Ingrezza.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 45 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 57 claims for Farxiga by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 141 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 46 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 68 claims for Trulicity by this doctor in 2024.
Neurocrine BioSciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported INGREZZA as an associated drug or biological on 126456 records involving 27390 distinct recipient NPIs. Public Medicare Part D data also shows 108 claims for Ingrezza by this doctor in 2024.
Teva Pharmaceuticals USA, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AUSTEDO XR as an associated drug or biological on 86263 records involving 23643 distinct recipient NPIs. Public Medicare Part D data also shows 19 claims for Austedo Xr by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $136.22 | 37.2% | 5 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $69.28 | 18.9% | 3 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $37.99 | 10.4% | 2 | 2025 |
| Corcept Therapeutics | Unresolved — no canonical attribution shown | $37.32 | 10.2% | 1 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $32.15 | 8.8% | 2 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $27.39 | 7.5% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $25.63 | 7.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $365.98 | 15 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FANAPT Normalized: fanapt |
Drug | Vanda Pharmaceuticals Inc. | $136.22 | 5 | 2025 |
Source payment records
|
|||||
| HETLIOZ Normalized: hetlioz |
Drug | Vanda Pharmaceuticals Inc. | $136.22 | 5 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $45.77 | 2 | 2025 |
Source payment records
|
|||||
| Korlym Normalized: korlym |
Drug | Corcept Therapeutics | $37.32 | 1 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $32.15 | 2 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $27.39 | 1 | 2025 |
Source payment records
|
|||||
| KISUNLA Normalized: kisunla |
Drug | Lilly USA, LLC | $25.63 | 1 | 2025 |
Source payment records
|
|||||
| UZEDY Normalized: uzedy |
Drug | Teva Pharmaceuticals USA, Inc. | $23.51 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $19.14 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $19.14 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $18.85 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| AUSTEDO XR austedo xr |
2025 | Austedo Xr | 2024 | 19 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| INGREZZA ingrezza |
2025 | Ingrezza | 2024 | 108 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
45 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
57 | 13 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
141 | 22 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
46 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
68 | 13 |
| Neurocrine BioSciences, Inc. Exact reporting entity; no affiliate inference |
2025 | INGREZZA open payments reported associated product |
CMS Open Payments — General Payments 126456 supporting records · 27390 recipient NPIs · example record 1242766729 |
Ingrezza · 2024 Exact normalized brand match · 1 Part D row |
108 | 12 |
| Teva Pharmaceuticals USA, Inc. Exact reporting entity; no affiliate inference |
2025 | AUSTEDO XR open payments reported associated product |
CMS Open Payments — General Payments 86263 supporting records · 23643 recipient NPIs · example record 1247244228 |
Austedo Xr · 2024 Exact normalized brand match · 1 Part D row |
19 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1977 | 277 |
| Amlodipine Besylate | Amlodipine Besylate | 1676 | 242 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1512 | 192 |
| Gabapentin | Gabapentin | 1029 | 152 |
| Metformin Hcl | Metformin Hcl | 869 | 138 |
| Pantoprazole Sodium | Pantoprazole Sodium | 781 | 115 |
| Carvedilol | Carvedilol | 771 | 104 |
| Lisinopril | Lisinopril | 731 | 114 |
| Metoprolol Tartrate | Metoprolol Tartrate | 716 | 97 |
| Losartan Potassium | Losartan Potassium | 710 | 96 |
| Omeprazole | Omeprazole | 706 | 108 |
| Tamsulosin Hcl | Tamsulosin Hcl | 677 | 103 |
| Furosemide | Furosemide | 653 | 100 |
| Donepezil Hcl | Donepezil Hcl | 639 | 81 |
| Famotidine | Famotidine | 561 | 84 |
| Trazodone Hcl | Trazodone Hcl | 547 | 91 |
| Azithromycin | Azithromycin | 533 | 308 |
| Zafirlukast | Zafirlukast | 533 | 73 |
| Quetiapine Fumarate | Quetiapine Fumarate | 524 | 73 |
| Januvia | Sitagliptin Phosphate | 523 | 65 |
| Alendronate Sodium | Alendronate Sodium | 504 | 77 |
| Lactulose | Lactulose | 502 | 89 |
| Divalproex Sodium | Divalproex Sodium | 487 | 66 |
| Potassium Chloride | Potassium Chloride | 471 | 73 |
| Memantine Hcl | Memantine Hcl | 464 | 65 |
| Glipizide | Glipizide | 463 | 60 |
| Oxybutynin Chloride | Oxybutynin Chloride | 461 | 55 |
| Levetiracetam | Levetiracetam | 456 | 51 |
| Ibuprofen | Ibuprofen | 411 | 119 |
| Omeprazole-Sodium Bicarbonate | Omeprazole/Sodium Bicarbonate | 393 | 51 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 390 | 62 |
| Risperidone | Risperidone | 384 | 58 |
| Olanzapine | Olanzapine | 382 | 49 |
| Tramadol Hcl | Tramadol Hcl | 378 | 72 |
| Finasteride | Finasteride | 374 | 60 |
| Eliquis | Apixaban | 371 | 56 |
| Simvastatin | Simvastatin | 358 | 60 |
| Clopidogrel | Clopidogrel Bisulfate | 328 | 49 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 321 | 102 |
| Allopurinol | Allopurinol | 317 | 51 |
| Dexamethasone | Dexamethasone | 298 | 203 |
| Metformin Er Gastric | Metformin Hcl | 283 | 34 |
| Mirtazapine | Mirtazapine | 278 | 45 |
| Hydrochlorothiazide | Hydrochlorothiazide | 275 | 40 |
| Metoprolol Succinate | Metoprolol Succinate | 273 | 41 |
| Fenofibrate | Fenofibrate Nanocrystallized | 268 | 32 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 266 | 190 |
| Lamotrigine | Lamotrigine | 266 | 33 |
| Fenofibrate | Fenofibrate | 251 | 35 |
| Valsartan | Valsartan | 236 | 40 |
| Mupirocin | Mupirocin | 229 | 90 |
| Diclofenac Sodium | Diclofenac Sodium | 227 | 61 |
| Ketoconazole | Ketoconazole | 227 | 66 |
| Fluticasone Propionate | Fluticasone Propionate | 224 | 45 |
| Escitalopram Oxalate | Escitalopram Oxalate | 222 | 32 |
| Sertraline Hcl | Sertraline Hcl | 221 | 36 |
| Baclofen | Baclofen | 219 | 29 |
| Montelukast Sodium | Montelukast Sodium | 213 | 37 |
| Benztropine Mesylate | Benztropine Mesylate | 190 | 26 |
| Hydralazine Hcl | Hydralazine Hcl | 183 | 34 |
| Sucralfate | Sucralfate | 179 | 22 |
| Vascepa | Icosapent Ethyl | 175 | 28 |
| Buspirone Hcl | Buspirone Hcl | 174 | 23 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 171 | 34 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 170 | 26 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 165 | 42 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 163 | 23 |
| Colchicine | Colchicine | 159 | 28 |
| Aripiprazole | Aripiprazole | 150 | 27 |
| Megestrol Acetate | Megestrol Acetate | 146 | 28 |
| Jardiance | Empagliflozin | 141 | 22 |
| Nystatin | Nystatin | 141 | 49 |
| Clonidine Hcl | Clonidine Hcl | 140 | 40 |
| Latanoprost | Latanoprost | 140 | 19 |
| Pioglitazone Hcl | Pioglitazone Hcl | 139 | 18 |
| Promethazine Hcl | Promethazine Hcl | 133 | 91 |
| Xarelto | Rivaroxaban | 133 | 16 |
| Duloxetine Hcl | Duloxetine Hcl | 130 | 22 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 128 | 23 |
| Midodrine Hcl | Midodrine Hcl | 128 | 21 |
| Propranolol Hcl | Propranolol Hcl | 127 | 17 |
| Dexlansoprazole Dr | Dexlansoprazole | 126 | 21 |
| Gemfibrozil | Gemfibrozil | 123 | 14 |
| Divalproex Sodium Er | Divalproex Sodium | 121 | 18 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 121 | 81 |
| Enulose | Lactulose | 113 | 31 |
| Zolpidem Tartrate | Zolpidem Tartrate | 112 | 26 |
| Ingrezza | Valbenazine Tosylate | 108 | 12 |
| Spironolactone | Spironolactone | 108 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 108 | 36 |
| Lidocaine | Lidocaine | 107 | 34 |
| Atenolol | Atenolol | 106 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 106 | 22 |
| Gemtesa | Vibegron | 105 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 102 | 23 |
| Paroxetine Hcl | Paroxetine Hcl | 102 | 12 |
| Tradjenta | Linagliptin | 101 | 14 |
| Carbamazepine | Carbamazepine | 99 | suppressed |
| Ozempic | Semaglutide | 98 | 16 |
| Humulin R | Insulin Regular, Human | 97 | 26 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 97 | 34 |
| Prednisone | Prednisone | 96 | 19 |
| Benazepril Hcl | Benazepril Hcl | 95 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 95 | 22 |
| Linzess | Linaclotide | 92 | 15 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 90 | 15 |
| Myrbetriq | Mirabegron | 90 | 13 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 87 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 86 | 13 |
| Alcohol Pads | Alcohol Antiseptic Pads | 84 | 18 |
| Lovastatin | Lovastatin | 84 | 11 |
| Cyclosporine | Cyclosporine | 83 | 13 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 82 | 19 |
| Warfarin Sodium | Warfarin Sodium | 82 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 79 | 12 |
| Primidone | Primidone | 76 | suppressed |
| Glimepiride | Glimepiride | 75 | 12 |
| Icosapent Ethyl | Icosapent Ethyl | 74 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 71 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 71 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 70 | 65 |
| Metronidazole | Metronidazole | 69 | 57 |
| Ondansetron Hcl | Ondansetron Hcl | 69 | 29 |
| Solifenacin Succinate | Solifenacin Succinate | 69 | suppressed |
| Trulicity | Dulaglutide | 68 | 13 |
| Ropinirole Hcl | Ropinirole Hcl | 67 | suppressed |
| Amoxicillin | Amoxicillin | 64 | 53 |
| Lithium Carbonate | Lithium Carbonate | 64 | suppressed |
| Lacosamide | Lacosamide | 63 | suppressed |
| Donepezil Hcl Odt | Donepezil Hcl | 62 | suppressed |
| Ezetimibe | Ezetimibe | 62 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 60 | suppressed |
| Digoxin | Digoxin | 60 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 60 | suppressed |
| Pregabalin | Pregabalin | 60 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 59 | 12 |
| Haloperidol | Haloperidol | 59 | suppressed |
| Lorazepam | Lorazepam | 59 | 21 |
| Colesevelam Hcl | Colesevelam Hcl | 58 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 58 | 38 |
| Farxiga | Dapagliflozin Propanediol | 57 | 13 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 55 | 18 |
| Methimazole | Methimazole | 55 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 54 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 54 | suppressed |
| Constulose | Lactulose | 53 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 53 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 52 | suppressed |
| Methocarbamol | Methocarbamol | 52 | suppressed |
| Entresto | Sacubitril/Valsartan | 51 | suppressed |
| Amantadine | Amantadine Hcl | 50 | suppressed |
| Hydrocortisone | Hydrocortisone | 50 | 19 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 49 | 45 |
| Febuxostat | Febuxostat | 49 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 49 | 15 |
| Nystop | Nystatin | 48 | 19 |
| Ziprasidone Hcl | Ziprasidone Hcl | 47 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 46 | suppressed |
| Meloxicam | Meloxicam, Submicronized | 46 | suppressed |
| Mounjaro | Tirzepatide | 46 | suppressed |
| Brilinta | Ticagrelor | 45 | suppressed |
| Olanzapine Odt | Olanzapine | 43 | suppressed |
| Lamotrigine Odt | Lamotrigine | 42 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 42 | suppressed |
| Ztlido | Lidocaine | 42 | suppressed |
| Cephalexin | Cephalexin | 41 | 37 |
| Nifedipine Er | Nifedipine | 41 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 40 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 40 | suppressed |
| Levofloxacin | Levofloxacin | 40 | 29 |
| Fenofibrate | Fenofibrate,micronized | 39 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 39 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 38 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 38 | suppressed |
| Permethrin | Permethrin | 38 | 25 |
| Temazepam | Temazepam | 38 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 38 | suppressed |
| Alprazolam | Alprazolam | 37 | suppressed |
| Celecoxib | Celecoxib | 37 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 37 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 36 | 18 |
| Mometasone Furoate | Mometasone Furoate | 36 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 36 | suppressed |
| Valproic Acid | Valproic Acid | 36 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | suppressed |
| Calcitriol | Calcitriol | 35 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 35 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 35 | suppressed |
| Naproxen-Esomeprazole Mag | Naproxen/Esomeprazole Mag | 35 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 35 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 34 | suppressed |
| Ibu | Ibuprofen | 34 | 16 |
| Topiramate | Topiramate | 34 | suppressed |
| Budesonide | Budesonide | 33 | suppressed |
| Niacin Er | Niacin | 33 | suppressed |
| Nitroglycerin | Nitroglycerin | 33 | 11 |
| Glipizide Er | Glipizide | 32 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 31 | suppressed |
| Ondansetron Odt | Ondansetron | 31 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 30 | suppressed |
| Klor-Con M20 | Potassium Chloride | 30 | suppressed |
| Loperamide | Loperamide Hcl | 30 | 13 |
| Sodium Chloride | 0.9 % Sodium Chloride | 30 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 30 | 22 |
| Alogliptin | Alogliptin Benzoate | 29 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 29 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 29 | suppressed |
| Aripiprazole Odt | Aripiprazole | 28 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 28 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 28 | suppressed |
| Mupirocin | Mupirocin Calcium | 28 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 28 | suppressed |
| Zileuton Er | Zileuton | 28 | suppressed |
| Acarbose | Acarbose | 27 | suppressed |
| Lubiprostone | Lubiprostone | 27 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 26 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 26 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 26 | suppressed |
| Invokana | Canagliflozin | 26 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 26 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 25 | suppressed |
| Acyclovir | Acyclovir | 24 | 14 |
| Diltiazem 24hr Er | Diltiazem Hcl | 24 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 24 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 23 | suppressed |
| Entacapone | Entacapone | 23 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 23 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 23 | 13 |
| Paxlovid | Nirmatrelvir/Ritonavir | 23 | 23 |
| Folic Acid | Folic Acid | 22 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 22 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 22 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 21 | suppressed |
| Metformin Er Osmotic | Metformin Hcl | 21 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 21 | 11 |
| Bumetanide | Bumetanide | 20 | suppressed |
| Chlorthalidone | Chlorthalidone | 20 | suppressed |
| Clozapine | Clozapine | 20 | suppressed |
| Dutasteride | Dutasteride | 20 | suppressed |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 20 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 19 | suppressed |
| Austedo Xr | Deutetrabenazine | 19 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 19 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 19 | suppressed |
| Ranolazine Er | Ranolazine | 19 | suppressed |
| Repatha Sureclick | Evolocumab | 19 | suppressed |
| Clotrimazole | Clotrimazole | 18 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 18 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 18 | suppressed |
| Glyburide | Glyburide | 18 | suppressed |
| Minoxidil | Minoxidil | 18 | suppressed |
| Naproxen | Naproxen | 18 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 18 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 17 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 17 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 17 | suppressed |
| Meloxicam | Meloxicam | 17 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 17 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 17 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 16 | suppressed |
| Acetylcysteine | Acetylcysteine | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 15 | suppressed |
| Bupropion Xl | Bupropion Hcl | 15 | suppressed |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | 15 | 12 |
| Humalog | Insulin Lispro | 15 | suppressed |
| Novolin R | Insulin Regular, Human | 15 | suppressed |
| Paliperidone Er | Paliperidone | 15 | suppressed |
| Risperidone Odt | Risperidone | 15 | suppressed |
| Arformoterol Tartrate | Arformoterol Tartrate | 14 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 14 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Pentoxifylline | Pentoxifylline | 14 | suppressed |
| Restasis | Cyclosporine | 14 | suppressed |
| Trospium Chloride | Trospium Chloride | 14 | suppressed |
| Bicalutamide | Bicalutamide | 13 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 13 | suppressed |
| Cholestyramine Light | Cholestyramine | 13 | suppressed |
| Creon | Lipase/Protease/Amylase | 13 | suppressed |
| Ibuprofen-Famotidine | Ibuprofen/Famotidine | 13 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 13 | suppressed |
| Isibloom | Desogestrel-Ethinyl Estradiol | 13 | suppressed |
| Mesalamine | Mesalamine | 13 | suppressed |
| Movantik | Naloxegol Oxalate | 13 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 13 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Azelastine-Fluticasone | Azelastine/Fluticasone | 12 | suppressed |
| Butalbital-Aspirin-Caffeine | Butalbital/Aspirin/Caffeine | 12 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 12 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 12 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 12 | suppressed |
| Itraconazole | Itraconazole | 12 | suppressed |
| Levonorgestrel-Eth Estradiol | Levonorgestrel/Ethin.Estradiol | 12 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 12 | suppressed |
| Metolazone | Metolazone | 12 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 12 | suppressed |
| Nateglinide | Nateglinide | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 12 | suppressed |
| Rifampin | Rifampin | 12 | suppressed |
| Trulance | Plecanatide | 12 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 12 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Comfort Ez Insulin Syringe | Syringe And Needle,insulin,1ml | 11 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Guanfacine Hcl Er | Guanfacine Hcl | 11 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 11 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 11 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 11 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 11 | suppressed |
| Roflumilast | Roflumilast | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $365.98 · 15 records | Vanda Pharmaceuticals Inc. | AIRSUPRA, AUSTEDO XR, EVENITY, FANAPT, HETLIOZ, INGREZZA, KISUNLA, Korlym, OTEZLA, REPATHA, UZEDY | 7 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Austedo Xr play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error